Skip to main content
TipRanks
Go Ultimate75% OFF

Anti-Microbial Savior BioteQ Co., Ltd. (6864) Financial Statements

Anti-Microbial Savior BioteQ Co., Ltd. Financial Overview

Anti-Microbial Savior BioteQ Co., Ltd.'s market cap is currently NT$1.43B. The company's EPS TTM is NT$-2.56; its P/E ratio is -14.45; Anti-Microbial Savior BioteQ Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 706.00KNT$ 612.00KNT$ 728.00KNT$ 2.70MNT$ 88.00K
Gross ProfitNT$ -10.81MNT$ 144.00KNT$ -10.18MNT$ 1.29MNT$ 47.00K
Operating IncomeNT$ -95.98MNT$ -76.48MNT$ -59.91MNT$ -43.37MNT$ -28.30M
EBITDANT$ -84.85MNT$ -63.67MNT$ -46.24MNT$ -30.17MNT$ -19.62M
Net IncomeNT$ -93.60MNT$ -74.52MNT$ -51.78MNT$ -31.74MNT$ -22.35M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 466.22MNT$ 194.13MNT$ 78.43MNT$ 131.11MNT$ 166.58M
Total AssetsNT$ 520.41MNT$ 248.18MNT$ 128.05MNT$ 181.96MNT$ 221.16M
Total DebtNT$ 1.23MNT$ 2.39MNT$ 1.38MNT$ 3.99MNT$ 14.14M
Net DebtNT$ -464.99MNT$ -191.74MNT$ -77.04MNT$ -127.13MNT$ -152.44M
Total LiabilitiesNT$ 9.92MNT$ 10.87MNT$ 6.99MNT$ 9.77MNT$ 17.23M
Stockholders' EquityNT$ 510.49MNT$ 237.31MNT$ 121.05MNT$ 172.19MNT$ 203.93M
Cash Flow
Free Cash FlowNT$ -84.56MNT$ -72.52MNT$ -49.78MNT$ -38.41MNT$ -23.41M
Operating Cash FlowNT$ -77.72MNT$ -64.15MNT$ -48.26MNT$ -30.66MNT$ -20.13M
Investing Cash FlowNT$ -7.97MNT$ -8.32MNT$ -1.78MNT$ 7.66MNT$ -4.27M
Financing Cash FlowNT$ 357.79MNT$ 188.16MNT$ -2.65MNT$ -12.46MNT$ 98.62M

Currency in TWD

Anti-Microbial Savior BioteQ Co., Ltd. Earnings and Revenue History

-100M-50M050M-30000 %-20000 %-10000 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin

Anti-Microbial Savior BioteQ Co., Ltd. Liabilities to Assets

0200M400M600M0 %3 %6 %9 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Anti-Microbial Savior BioteQ Co., Ltd. Cash Flow

-100M0100M200M300M400M202020212022202320242025OperatingInvestingFinancing

Anti-Microbial Savior BioteQ Co., Ltd. Forecast EPS vs Actual EPS